Moderna Announces Health Canada Approves its COVID-19 Vaccine
Moderna, Inc. (NASDAQ:MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced Health Canada has
Moderna Highlights New Clinical Data on its COVID-19 Vaccine
mRNA-1273 remains highly effective against COVID-19 in real-world effectiveness study during surge in Delta cases
New analysis of open-label portion of Phase
RedHill Biopharma Ltd. (NASDAQ:RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced preliminary top-line data from the 475-patient global Phase 2/3